Clinical Trial Update: Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating preoperative Bintrafusp Alfa in operable urothelial carcinoma of the bladder is in progress.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: Queen Mary University of London | Conditions: Transitional Cell Carcinoma, Bladder Cancer | Phase 2 | Status: UNKNOWN